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Abstract
Background: One of the most important global pathogens infecting all age groups is Streptococcus pneumoniae
(the ‘pneumococcus’). Pneumococci reside in the paediatric nasopharynx, where they compete for space and
resources, and one competition strategy is to produce a bacteriocin (antimicrobial peptide or protein) to attack
other bacteria and an immunity protein to protect against self-destruction. We analysed a collection of 336 diverse
pneumococcal genomes dating from 1916 onwards, identified bacteriocin cassettes, detailed their genetic composition
and sequence diversity, and evaluated the data in the context of the pneumococcal population structure.
Results: We found that all genomes maintained a blp bacteriocin cassette and we identified several novel blp cassettes
and genes. The composition of the ‘bacteriocin/immunity region’ of the blp cassette was highly variable: one cassette
possessed six bacteriocin genes and eight putative immunity genes, whereas another cassette had only one of each.
Both widely-distributed and highly clonal blp cassettes were identified. Most surprisingly, one-third of pneumococcal
genomes also possessed a cassette encoding a novel circular bacteriocin that we called pneumocyclicin, which
shared a similar genetic organisation to well-characterised circular bacteriocin cassettes in other bacterial species.
Pneumocyclicin cassettes were mainly of one genetic cluster and largely found among seven major pneumococcal
clonal complexes.
Conclusions: These detailed genomic analyses revealed a novel pneumocyclicin cassette and a wide variety of blp
bacteriocin cassettes, suggesting that competition in the nasopharynx is a complex biological phenomenon.
Background
The pneumococcus is among the most important patho-
gens worldwide: in 2000, ~14.5 million estimated cases
of life-threatening pneumococcal diseases like pneumo-
nia, bacteraemia and meningitis occurred and ~826,000
children died [1]. Pneumococcal disease can be treated
with antibiotics, but antibiotic-resistant pneumococci are
found worldwide, e.g. 60 % of pneumococci recovered in
Asia are multidrug-resistant [2]. Pneumococcal conjugate
vaccines (PCVs) are administered to children in many de-
veloped countries and some resource-poor countries,
which has significantly reduced morbidity and mortality
[3]; however, current PCVs only protect against 10 or 13
pneumococcal types, depending on the vaccine. Pneumo-
coccal types are defined by an antigenic polysaccharide
capsule or ‘serotype’: over 90 different serotypes have been
characterised and new ones continue to be discovered
[4, 5]. Consequently, after PCV is introduced, vaccine-
serotype disease decreases and nonvaccine-serotype dis-
ease often increases [6]. The prevalence of commensal
pneumococci in the paediatric nasopharynx, its ecological
niche, generally remains the same post-PCV, but reorders
in favour of nonvaccine serotypes [7]. Vaccine escape is
also possible and new variants can spread rapidly [8–10].
Nasopharyngeal colonisation of one or more pneumo-
coccal serotypes is ubiquitous among children and usu-
ally asymptomatic [11]. The composition of colonising
pneumococci fluctuates over time, indicating the import-
ance of intraspecies competition in pneumococcal ecology
[12, 13]. Understanding the dynamics of competition is
important in the context of understanding how perturba-
tions such as vaccine introduction affect the pneumococ-
cal population structure and result in changes in the
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pneumococci competing for space and nutrients in the
nasopharynx.
Bacteriocins are small, ribosomally-synthesised anti-
microbial peptides or proteins produced by bacteria to
inhibit other bacteria, and the producer strain has a ded-
icated immunity system that protects it from its own
bacteriocin. Bacteriocins are a diverse group of com-
pounds in terms of size, mode of action and immunity
mechanisms, and are produced by both Gram-positive
and Gram-negative bacteria. Given that the producer
and target strains are often of the same bacterial species,
the bacteriocins are largely believed to be involved in
competition for limited resources within an ecological
niche, but they may also be contributing to the mainten-
ance of microbial diversity at a population level [14–16].
Pneumococci have been shown to mediate intraspecies
competition by the production of bacteriocins encoded
by the highly variable blp (also known as spi/pnc) cas-
sette [17–22]. This cassette typically contains several
bacteriocin-like peptide genes, clustered together with
genes for putative membrane proteins that may have
functions in immunity, in a region labelled the ‘bacteri-
ocin/immunity region’ (BIR). The predicted pneumococcal
bacteriocin peptides show homology to type II bacteriocin
precursor peptides, and consist of a conserved N-terminal
leader sequence ending in a double glycine motif and an
alanine/glycine-rich mature peptide [17]. Previous studies
have demonstrated the existence of genes for at least 10
such peptides within the blp cassette [17, 20–22].
The blp locus is regulated by quorum sensing, in a
manner reminiscent of the regulation of competence by
ComCDE [17, 18]. This is typically effected by a three-
component system consisting of sensor histidine kinase
BlpH (SpiH), response regulator BlpR (SpiR2), and pep-
tide pheromone BlpC (SpiP). At high extracellular con-
centrations of BlpC the pheromone binds to BlpH, in
turn activating BlpR [23]. BlpR then binds to conserved
motifs in promoters, inducing expression of all genes in
the locus, resulting in the production of more BlpC and
bacteriocins. Similar to the bacteriocin-like peptides, BlpC
has an N-terminal leader sequence [17, 18]; upon recogni-
tion by the dedicated ABC transporter BlpAB (SpiABCD),
the signal peptide is cleaved off, and the mature peptide is
transported out of the cell [24]. Sequence analyses and
induction experiments showed that different BlpC se-
quences correspond to separate pherotypes, with no cross-
induction of the blp genes [17, 18].
The aims of our study were to: i) provide a detailed
characterisation and comparison of the blp bacteriocin
cassettes from a large and diverse set of historical and
modern pneumococcal genomes; ii) investigate cassette
diversity in the context of the pneumococcal population
structure; and iii) investigate the genetic stability of blp
cassettes over time. We classified the blp bacteriocin
cassettes based on gene content and nucleotide se-
quence, and revealed several novel cassette types. Sur-
prisingly, we also discovered evidence for a circular
bacteriocin cassette, which has not previously been de-
scribed among pneumococci.
Results
Presence, nomenclature and classification of blp cassettes
All 336 of the pneumococcal genomes investigated
(Additional file 1) had a blp bacteriocin cassette. In the
literature there are two sets of gene names associated
with these cassettes in pneumococci and we have identi-
fied additional novel genes in this study, adding to the
confusion around nomenclature. Therefore, the gene
names used in this study are presented in Table 1. Unre-
solvable ambiguities were encountered in seven cassette
assemblies and these were excluded from further analyses.
Sequences for the 329 remaining blp cassettes were sepa-
rated by gene content into 33 Categories and by sequence
similarity into 79 Groups. 79 Group prototype cassettes
were analysed further.
Description of the blp cassettes at the level of gene
organisation
The length of the blp bacteriocin gene cassettes ranged
from 9.1 to 17.5 kb (Fig. 1). All Categories had a number
of genes in common at the start and end of the cassette,
including the regulatory, ABC transporter and CAAX
protease genes (possibly related to bacteriocin self-
immunity [25]), and a membrane protein gene putatively
associated with immunity (Tables 1 and 2). One excep-
tion to this was that blpY and blpZ were missing in Cat-
egory 4, having been replaced by the remnants of an
insertion sequence (IS) element.
The demarcation of the ABC transporter genes (blpA)
and transport accessory protein gene (blpB) was highly
variable even within Categories, and the frequent div-
ision of blpA into multiple ORFs was consistent with
findings from previous studies [21, 22]. Son et al.
analysed the sequences of the transporter genes and
linked the frequent presence of frameshift-causing re-
peats and deletions in blpA to ‘cheater’ (immunity only,
non-inhibitory) phenotypes.
Located between the common genes, the composition
of the BIR was highly variable among Categories (Table 2).
The number of BIR genes ranged from 1–15 and included
structural bacteriocin genes, putative immunity genes, a
CAAX protease and genes with products of unknown
function.
Overall, most cassettes had one copy of each gene, al-
though Categories 22 and 28 had two copies of pncG and
Categories 22, 32 and 33 had two copies of blpL. In every
case, the paralogues were separated by multiple genes and
their sequences differed considerably. Furthermore, both
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blpK and a hybrid gene blpKN were present in Category
15. We found three additional hybrid blp bacteriocin
genes, resulting from the contraction of blpM + blpN in
Categories 21 and 30, and blpQ + blpM in Category 26. A
deletion in Category 20 fused blpJ + blpK, but left the cod-
ing sequences in separate frames, thus resulting in a differ-
ent ending for blpJ and the loss of function of blpK.
Interestingly, the BIR of Categories 30–33 contained
genes predicted to encode two novel class II bacteriocin
precursors (blpD and blpE), a novel putative immunity
protein (blpF), a CAAX protease (blpG) and a hypothet-
ical protein (blpV; Tables 1 and 2). blpV appeared to be
a partial bacteriocin precursor gene: its amino acid se-
quence contained two GxxxG motifs, and a typical class II
bacteriocin leader sequence was located directly upstream
but in a different frame. Another novel bacteriocin precur-
sor gene (blpW) was found in the BIR of Category 29. A
search of the NCBI non-redundant protein database
yielded no homologous sequences in other pneumococcal
genomes, but orthologues were found in Streptococcus
pseudopneumoniae [RefSeq:WP_001093252; 92 % iden-
tity] and Streptococcus mitis (GenBank:KEQ38555.1; 91 %
identity).
Cassettes belonging to Categories 9, 10, 28, 29, 32 and
33 contained one or two ORFs that, when considered to-
gether as a single gene (tdpA), encoded a protein with a
thioredoxin domain and a Gram-positive anchor do-
main. The sequence of the complete gene from Category
29 was found to be homologous to genes found in S. pseu-
dopneumoniae and Streptococcus mitis (99 % and 94 %
amino acid sequence identity, respectively). The products
of these orthologues were labelled as putative bacteriocin
transport accessory proteins [GenBank:EID24163; Gen-
Bank:EID31510] or transposases [RefSeq:WP_000744512;
RefSeq:WP_000795769].
Finally, it was known that blp bacteriocin gene clusters
often contain IS elements [17, 18, 21, 22] and we also
found that 40 of the 79 prototypes contained one or
more IS elements (49 in total), 34 of which were an
ISSpn7/IS1381-like sequence located in non-coding se-
quences upstream of blpM, blpMN1 or blpMN2, in all
prototypes of the Categories 19–25, 27–28 and 30–33.
The remaining IS elements were: ISSpn5 (n = 10);
IS1515 (n = 3); and ISSpn8 (n = 2).
Sequence diversity of predicted products of blp genes
(excluding ABC transporter genes and tdpA)
The blp bacteriocin cassettes each had four regulatory
genes: blpS, blpR, blpH and blpC. Based on amino acid
sequences of the deduced products, 13–26 allelic vari-
ants were revealed for each protein, although each pro-
tein had 2–3 predominant alleles (Additional file 2). It
was previously shown that allelic diversity of the peptide
pheromone BlpC corresponds to distinct pherotypes;
Table 1 blp genes and predicted functions of their products
Gene Synonym(s) Predicted function of productb
blpT – Hypothetical protein
blpS spiR1 LytTR DNA-binding domain protein
blpR spiR2 Response regulatorc
blpH spiH Histidine kinasec
blpC spiP Peptide pheromonec
blpB spiD Transport accessory protein
blpA spiABC ABC transporterc
blpI pncA Class II bacteriocin precursorc
blpJ pncD Class II bacteriocin precursorc
blpK pncE, pncE2 Class II bacteriocin precursorc
blpKN pncU Class II bacteriocin precursor (hybrid)
pncG – Membrane protein (putative function in
immunity)
blpL pncH Membrane protein (putative function in
immunity)
blpM pncI Class II bacteriocin precursorc
blpN pncJ Class II bacteriocin precursorc
blpMN1a – Class II bacteriocin precursor (hybrid)
blpMN2a – Class II bacteriocin precursor (hybrid)
blpP pncK Membrane protein (function in immunity)c
blpO pncV Class II bacteriocin precursor
pncM – Membrane protein (putative function in
immunity)
blpQ pncR Class II bacteriocin precursor
blpQMa – Class II bacteriocin precursor (hybrid)
pncT – Class II bacteriocin precursor
blpDa – Class II bacteriocin precursor
blpEa – Class II bacteriocin precursor
blpFa – Membrane protein (putative function in
immunity)
blpGa – CAAX protease (putative function in
immunity)
blpVa – Hypothetical protein
blpWa – Class II bacteriocin precursor
tdpA – Thioredoxin domain containing protein
pncW – Class II bacteriocin precursor
blpX pncN Membrane protein (putative function in
immunity)
blpY pncO CAAX protease (function in immunity)c
blpZ pncQ Membrane protein (putative function
in immunity)
pncP SP0547 CAAX protease (putative function
in immunity)
aNovel gene identified in this study.
bGenes with products marked with boldface font are found in all cassettes; the
remaining genes are found in the bacteriocin/immunity region (BIR).
cThe indicated function is supported by experimental evidence.
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Fig. 1 Schematic representation of the blp cassette Categories found in the pneumococcal genome collection. Genes are coloured according to the
predicted functions of their products. Depicted cassettes are Group prototypes belonging to each Category. The organisation of the ABC transporter genes
and the presence of insertion sequences are not representative of all cassettes in the labelled Category (see Methods section in main text)
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Table 2 Description of the 33 blp cassette Categories identified in 329 genomes
Cata Groups Genomes (n) Gene organisationb, c, d Pherogroup (blp Group)e
1 a, b 3 T S R H C B A W* Y Z P* B (1a), A (1b)
2 – 1 T S R H C B A K X Y Z P* A
3 – 3 T S R H C B A O M* X Y Z P* D
4 – 1 T S R H C B A M N P O P* B
5 a, b 2 T S R H C B A M N P O M* X Y Z P* A (5a), H/M (5b)
6 – 8 T S R H C B A M N P K G* L X Y Z P* A
7 a, b 3 T S R H C B A M N P O G* L X Y Z P* B (7a), D (7b)
8 a - h 15 T S R H C B A M N P O G* L M* X Y Z P* C (8a, d-f), H/M (8bc), D
(8 g), B (8 h)
9 – 1 T S R H C B A M N P O G* M* tdpA X Y Z P* A
10 a, b 2 T S R H C B A M N P O G* tdpA W* Y Z P* D (10ab)
11 – 8 T S R H C B A I O M* X Y Z P* B
12 – 1 T S R H C B A I J O M* X Y Z P* B
13 a, b 2 T S R H C B A I J O G* L M* X Y Z P* A (13a), B (13b)
14 a - h 94 T S R H C B A I J KN P O G* L M* X Y Z P* D (14ab), H/M (14 cd), B
(14e-h)
15 a, b 4 T S R H C B A I J KN P K G* L M* X Y Z P* A (15a), D (15b)
16 a, b 2 T S R H C B A I J K G* L M* X Y Z P* A (16a), B (16b)
17 a - e 21 T S R H C B A I J K G* L X Y Z P* A (17ab), H/M (17 cd),
B (17e)
18 – 1 T S R H C B A I J K M N P O M* X Y Z P* D
19 a - m 41 T S R H C B A I J K G* L M N P O M* X Y Z P* D (19ab, d, m), B (19c, l), C (19e),
H/M (19f-j), A (19 k)
20 – 2 T S R H C B A I J G* L M N P O M* X Y Z P* C
21 – 3 T S R H C B A I J K G* L MN1 P O M* X Y Z P* H/M
22 – 1 T S R H C B A I J K G* L M N P O G* L X Y Z P* D
23 a, b 26 T S R H C B A K G* L M N P O M* X Y Z P* H/M (23a), A (23b)
24 a - f 27 T S R H C B A Q T* G* M N P O M* X Y Z P* B (24a), H/M (24b, f), D (24 cd),
C (24e)
25 a - d 33 T S R H C B A Q T* G* M N P W* Y Z P* B (25ab), H/M (25c), C (25d)
26 – 1 T S R H C B A QM N P W* Y Z P* A
27 – 1 T S R H C B A I J K G* M N P W* Y Z P* C
28 – 1 T S R H C B A Q T* G* M N P O G* L tdpA W* Y Z P* D













Table 2 Description of the 33 blp cassette Categories identified in 329 genomes (Continued)
30 – 16 T S R H C B A D E F G V L MN2 P W* Y Z P* A
31 – 2 T S R H C B A D E F G V L M N P W* Y Z P* A
32 – 1 T S R H C B A D E F G V L M N P O G* L tdpA W* Y Z P* A
33 – 1 T S R H C B A D E F G V L M* M N P O G* L tdpA W* Y Z P* A
aCat = Category
bLetters represent blp genes; those marked with an asterisk represent genes with only a pnc name.
cLetters in boldface font represent bacteriocin precursor genes; those underlined represent membrane protein genes (with a putative function in immunity).
dInsertion sequences are not shown in this table.













based upon the BlpC peptide sequences there was evi-
dence for four distinctly different pherogroups A-D
(Table 2), which corresponded to the 6A, R6, P164 and
TIGR4 pherotypes plus minor variants, respectively, as
detailed in Additional file 3 [17, 18, 22]. The diversity of
BlpC was concentrated in the C-terminal half (the mature
peptide), after cleavage by the ABC transporter. The BlpC
pherogroups were associated with specific allelic versions
of histidine kinase BlpH and response regulator BlpR.
There was also a heterogeneous fifth group with mis-
matched BlpC/BlpH combinations and proteins encoded
by sequence regions derived from multiple pherogroups.
Sixteen different putative blp bacteriocin precursor
genes were identified among the cassettes: ten were de-
scribed previously [17, 18, 21]; three were novel (blpD,
blpE, blpW); and three were newly-identified hybrid
genes (blpMN1, blpMN2, blpQM; Table 1). blpQ, pncT
and pncW were classified as putative bacteriocin precur-
sor genes due to the encoded peptides containing a typ-
ical leader sequence, although they lacked other salient
features of bacteriocins, i.e. Ala/Gly-rich sequence and
GxxxG motifs [17]. The gene pncW was previously de-
scribed as a fusion gene with a mutated cleavage motif
[21]; however, in our dataset there were multiple proto-
types in which PncW had a presumably functional
double-glycine motif and thus we included it among the
putative bacteriocin precursors.
The number of blp bacteriocin precursor genes ranged
from 1–6 per cassette (Table 2). Most had 1–2 predom-
inant amino acid alleles, and some also had minor allelic
variants (Additional file 2). The peptides BlpM and BlpN
were previously shown to contribute to intraspecies com-
petition in a murine model of colonisation, and a difference
of five amino acids in bacteriocin BlpMN was sufficient to
change the inhibitory properties of a strain in overlay as-
says. Further in vitro mutagenesis work indicated that the
product of blpP, located directly downstream of blpMN,
mediates immunity against this bacteriocin [20].
The number of genes encoding putative immunity
proteins ranged from 1–7 per cassette (Table 2). Six
such genes were found within the BIR, and common
gene blpZ was located near the end of the bacteriocin
cassette. Based on the amino acid sequences, between
2–20 alleles per protein were identified, although each
putative immunity protein had 1–3 predominant alleles
(Additional file 2).
Three genes in the bacteriocin cassettes coded for pu-
tative CAAX amino terminal proteases: blpY and pncP,
located at the end of every cassette, and a novel gene
(blpG) within the BIR of prototypes 30 – 33. Several
major and minor alleles for BlpY and PncP, but only one
BlpG allele, were identified. Roles in immunity against
bacteriocins have been suggested for CAAX proteases:
they may contribute to immunity by processing or
degrading proteins, but their targets are unknown [17,
21, 25, 26]. In vitro site-directed mutagenesis indicated
that CAAX protease BlpY is essential for immunity and
bacteriocin activity [21].
Finally, two genes encoding hypothetical proteins were
identified in the blp bacteriocin cassettes: blpT is the
first gene present in all cassettes and most prototypes
possessed one of two major amino acid alleles at this
locus; and blpV was newly identified in this study in four
prototypes, all of which had identical BlpV sequences
(Additional file 2).
Molecular epidemiology of the blp bacteriocin cassettes
Category 14 was the most prevalent and widely-
distributed cassette: it was present in 94 pneumococci of
13 serotypes, recovered from 1939–2007 in 18 countries
around the world (Table 3). These pneumococci were
members of 15 different clonal complexes (CCs), seven
of which are major pneumococcal CCs circulating glo-
bally (Table 4; [27]). blp cassettes in Category 14 were
further divided into eight Groups, based on variation
among ~600 nucleotides across the 12.6 Kb cassette.
Variable nucleotide maps of the Group variation within
Categories are contained in Additional file 4.
Category 19 was genetically the most diverse type of
blp cassette: these cassettes were found in pneumococci
of 11 serotypes isolated from 1952–2006 in eight coun-
tries, and the pneumococci were members of 11 CCs. 13
different Groups could be identified based on variation
among ~1700 nucleotides across the 14.5 Kb cassette,
and these Groups could be clustered into three major
phylogenetic clusters based on the nucleotide sequences
(Additional file 4).
In contrast, Categories 30, 6 and 11 were found in
pneumococci isolated from several countries, but from a
single CC associated with 1–2 serotypes, as shown in
Tables 3 and 4. All eight examples of cassette Category 6
had nearly identical nucleotide sequences across the 11.2
Kb blp cassette, and they were found among CC1917F/A
pneumococci recovered over the last seven decades.
Category 30 and 11 blp cassettes were also nearly identi-
cal among modern pneumococci, although genomes of
older isolates of either CC236/271/32019F/A or CC1803
were not available to assess whether stability among Cat-
egories 30 and 11 persists over longer time periods, and
the same blp cassette sequences were not found among
any of the historical pneumococci of other CCs. Table 4
also shows that CCs generally possessed a blp cassette of
only one, or one predominant, Category. This was not
true for serotype and blp Category: among the most
prevalent serotypes each was associated with several blp
Categories (Additional file 5).
Category 6 cassettes were genetically stable, but there
were also Groups within Categories that appeared to be
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similarly stable over several decades and found in
widely-circulating CCs. Three examples were: i) Group
14a, identified in 61 genomes from 1952–2007, all but
two of which were in CC8123F (n = 39), CC19919A (n =
12) and CC6614/19F/9V (n = 8); ii) Group 23a, found in 21
genomes dating from 1967–2006, all but two of which
were CC1514; and iii) Group 24d, identified in 9 ge-
nomes from 1939–1999, all of which were CC11318C.
Further details are provided in Additional files 6 and 7.
Moreover, pneumococci are known to be recombinogenic
and able to exchange large DNA fragments between unre-
lated pneumococcal lineages [8, 10, 28, 29], therefore we
were interested in whether we could also identify evidence
for regions of blp cassette sequence that were shared be-
tween unrelated CCs. The assembled prototype blp cassette
sequences were thus aligned and inspected, and regions of
identical or nearly identical sequence were indeed found be-
tween sequences of different prototypes. Several examples
are shown in Fig. 2, which depicts shared blp cassette se-
quences between some of the major pneumococcal CCs,
the pattern of which was consistent with evidence for
recombination. Other examples of putative blp cassette
recombination can be found in Additional file 8.
Discovery of a novel pneumococcal circular bacteriocin
(pneumocyclicin) cassette
During the investigation of the blp cassette, we identified
a cluster of six genes located upstream of comAB in sev-
eral strains: sequence analyses and BLAST searches sug-
gested that this gene cluster, with a length of ~4.4 Kb,
encodes the biosynthetic locus of a novel circular bac-
teriocin, which we provisionally named pneumocyclicin.
This is the first report of circular bacteriocin cassettes
among pneumococci, although they have been described
in other Gram-positive species, including other Strepto-
coccus spp, as explained below.
The pneumocyclicin genes were designated pcyA-E
(pneumocyclicin A-E) and pfgR (pcyA-flanking gene re-
sponse regulator). Predicted functions and physicochem-
ical properties of their putative products are presented
in Table 5. The gene organisation of the pneumocyclicin
cassette was similar to that of previously identified circu-
lar bacteriocin cassettes [30–32], particularly that of uber-
olysin from Streptococcus uberis [33] and circularin A
from Clostridium beijerinckii [34], as shown in Fig. 3a.
The first gene in the pneumocyclicin cassette, pfgR,
encodes a transcriptional regulator with an N-terminal
Table 3 Summary metadata for the blp bacteriocin cassettes
blp Categorya Genomes (n) Years of isolation Countries (n) CCs (n) Serotypes (n) blp Groups (n)
14 94 1939-2007 18 15 13 8
19 41 1952-2006 8 11 11 13
25 33 1945-2004 8 11 8 4
24 27 1939-2006 4 7 10 6
23 26 1967-2006 8 4 4 2
17 21 1952-2008 6 4 5 5
8 15 1948-2006 5 9 7 8
15 4 2005-2007 1 2 2 2
1 3 1916-2003 2 2 3 2
3 3 1952-1963 1 2 2 0
7 3 1978-1999 2 2 2 2
5 2 1939, 1976 1 2 1 2
10 2 1962, 1988 2 2 2 2
13 2 1943, 1952 2 2 2 2
16 2 1989, 2004 2 2 2 2
30 16 1997-2006 2 1 2 0
6 8 1937-2006 6 1 2 0
11 8 1997-2004 3 1 1 0
21 3 1997-2004 2 1 1 0
31 2 1995, 1999 1 1 1 0
20 2 2006 1 1 1 0
Otherb 12 1969-2007 1 ea 1 ea 1 ea 0
ablp Categories are numbered.
b‘Other’ indicates blp Categories that were each only represented by a single pneumococcal genome.
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helix-turn-helix XRE-family like domain. pcyA encodes
the pneumocyclicin precursor, a 98-amino acid polypep-
tide from which pneumocyclicin could be derived by
removal of an N-terminal leader sequence and circular-
isation of the remaining peptide [30–32]. Sequence ana-
lyses, a high isoelectric point (pI) and positively-charged
residues indicated that pneumocyclicin belongs to the
class IIc(i) circular bacteriocins, which have limited se-
quence similarity but share a common protein architec-
ture consisting of four or five α-helices that form a
saposin fold (Fig. 3b) [35].
The structural bacteriocin gene was followed by three
genes encoding two putative membrane proteins (pcyB
and pcyC) and one soluble ABC transporter ATP-binding
protein (pcyD; Fig. 3a). The specific functions of PcyB and
PcyC equivalents in other known cassettes are still unclear,
but evidence points to roles in bacteriocin maturation
and/or transport and immunity. PcyC, like CclC, As-48C,
CirC and UblC, is a member of a protein family contain-
ing the domain of unknown function 95 (DUF95) [36].
The genes as-48B and cirBCD have been shown to be
essential for production of AS-48 and circularin A, re-
spectively, and as-48C and cirBD are required for full
immunity to these bacteriocins [34, 37]. Finally, pcyE
encodes another putative membrane protein. In the AS-
48 and circularin A cassettes, the equivalents as-48D1 and
cirE encode small hydrophobic peptides confirmed to
be involved in immunity, but not sufficient for full
resistance to these bacteriocins [34, 37]. However, the
predicted PcyE protein was larger and contained more
putative membrane spanning helices than either
As-48D or CirE.
The cassettes for AS-48, carnocyclin A and circularin
A each contain genes for a multicomponent ABC
Table 4 Distribution of each blp cassette Category among genomes of major pneumococcal clonal complexes (CCs)
Number of genomes with blp cassettes of the different Categories, stratified by CCb:
CCserotype a 14 19 25 24 23 17 8 15 1 3 7 5 10 13 16 30 6 11 21 31 20 Other Total
8123F 39 39
10946A 22 22
236/271/32019F/A 1 16 2 1 20
12414 2 1 16 19
1514 19 19
None4119A 14 1 15
19919A 12 12
1803 1 8 1 10
11318C 9 1 10
6614/19F/9V 8 2 10
43923F 9 9
21812F/7F 8 1 9




17619A 1 5 1 7
3856B 6 6
490misc c 2 1 1 1 1 6
2474/19A 5 5
3061 4 4
6211A 3 1 4
Otherd 10 6 8 4 2 0 10 4 2 3 3 2 2 0 1 0 0 0 3 0 2 9 71
Total 94 41 33 27 26 21 15 4 3 3 3 2 2 2 2 16 8 8 3 2 2 12 329
aCC = clonal complex; superscript indicates the predominant serotype associated with that CC.
b ‘Other’ indicates blp Categories that were each only represented by a single pneumococcal genome.
cMisc =miscellaneous: genomes in CC490 encoded serotypes 2, 10 F, 18 F, 22A, 6B or 6C.
dEach of the Other CCs contributed ≤3 isolates to the Other CCs total.
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transporter downstream of the genes minimally required
for bacteriocin production [34, 36, 38]. Although not es-
sential, these genes were shown to enhance both pro-
duction of and immunity to AS-48 [38]. Interestingly,
the comAB operon located downstream of the pcy genes
also encodes an ABC transporter, which is known to
process and transport the competence-stimulating pep-
tide CSP (Fig. 3a) [39].
Prevalence and sequence diversity of the pneumocyclicin
cassette
The pneumocyclicin cassette was present in 115 (34 %)
of the 336 pneumococcal genomes in our dataset. Forty
distinct nucleotide alleles described the 115 pneumocy-
clicin cassettes and they formed two sequence clusters,
as shown in Fig. 3c. The overall nucleotide diversity was
low, with a mean p-distance of 0.002 among all alleles
Fig. 2 Examples of blp Groups and putative recombination blocks shared between different pneumococcal clonal complexes. Genes are coloured
according to sequence similarity (or lack thereof), with matching colours indicating identical or highly similar sequences. Insertion sequences are
not shown
Table 5 Properties of pneumocyclicin genes and their deduced products
Gene Deduced product
Name Length (bp) Predicted function Size (kDa) pIa
pfgR 894 XRE family transcriptional regulator 34.5 4.9
pcyA 297 Circular bacteriocin (uberolysin/ circularin A family) precursor 10.1 10.4
pcyB 1137 Membrane protein (putative function in maturation/immunity) 44.3 9.6
pcyC 483 Membrane protein (putative function in maturation/immunity) 18.3 9.3
pcyD 597 ABC transporter ATP-binding protein 22.5 5
pcyE 492 Membrane protein (putative function in immunity) 18.9 9
apI = predicted isoelectric point of the deduced protein.
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and 0.001 within each sequence cluster. Sequence differ-
ences within and between clusters were concentrated
within pfgR and the non-coding sequence between pfgR
and pcyA. Four adjacent ATTT repeats were identified
within pcyB (encoding one of the membrane proteins);
several alleles from both clusters had ±1 copy of this re-
peat, which resulted in a frameshifted coding sequence.
This is reminiscent of the four nucleotide repeat seen
within blpA of the blp bacteriocin cassette and associ-
ated with the ‘cheater phenotype’ by Son et al. [22].
Molecular epidemiology of the pneumocyclicin cassettes
Pneumocyclicin cassettes of both phylogenetic clusters
were found in genomes dating from 1939 onwards. Clus-
ter A alleles were by far the more prevalent of the two
alleles, detected in 106 pneumococci recovered from
1939–2008 in 12 different countries. The pneumococci
with cluster A alleles were members of 21 different CCs
and were of 20 different serotypes. The nine cluster B al-
leles were found in pneumococci of seven different CCs
and serotypes, and were recovered from 1939–2007.
Among the 115 genomes with a pneumocyclicin cas-
sette, 80 % (n = 92) were members of one of seven CCs,
six of which are major CCs circulating globally and
CC1094 is a major South African CC (Table 6; [27]).
Apart from one exception in a CC124 genome, all major
CCs possessed cluster A pneumocyclicin alleles. Seven
of these alleles were the most prevalent and together
they represented 71 % (n = 75) of all 106 cluster A alleles.
The sequences of these seven alleles were very similar,
Fig. 3 The pneumocyclicin cassette putatively encoding a newly-identified circular bacteriocin within the pneumococcal population. a. Comparison of
the gene organisation of the pneumocyclicin cassette with those of class IIc(i) circular bacteriocins AS-48, carnocyclin A, circularin A and uberolysin.
The genes comA and comB, adjacent to but not considered to be part of the pneumocyclicin cassette, were included to demonstrate that the synteny
with other circular bacteriocin cassettes extends beyond the minimal cassettes and includes the downstream ABC transporter genes. b. Comparison of
the pneumocyclicin precursor peptide sequence and predicted secondary structure with that of other class IIc(i) circular bacteriocins. Figure adapted
from Martin-Visscher et al. [35]. c. Neighbour-joining tree demonstrating two distinct clusters of alleles representing the 115 pneumocyclicin cassettes
in the study dataset
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differing at only 12 nucleotides in total across the ~4.4 Kb
pneumocyclicin cassette.
Discussion
Bacteriocins have generated renewed interest because of
the major problems associated with antibiotic-resistant
bacteria and the possible role of bacteriocins as alterna-
tives to conventional antibiotics. There are many publi-
cations that describe the array of bacteriocins produced
by many Gram-positive and Gram-negative bacteria.
Comparatively less is known about pneumococcal bacte-
riocins, although several studies have delineated the
genetic structure, function of some genes, and diversity
of pneumococcal blp bacteriocin cassettes on a small
number of pneumococcal strains, at a time when large
scale sequencing was a challenge and limited genome
data were available [17, 20–22]. In this study we found
that blp bacteriocin cassettes were ubiquitous among a
diverse set of pneumococcal genomes that dated back to
1916, in a variety of permutations with respect to both
the genetic background of the host pneumococcus and
the genetic composition of the blp bacteriocin cassette.
Several novel genes and blp bacteriocin cassette types
were also revealed.
Most surprisingly, we discovered that in addition to a
blp bacteriocin cassette, a third of the pneumococcal ge-
nomes also possessed a cassette encoding a putative
circular bacteriocin. To date, circular bacteriocins have
predominantly been identified among the phylum Firmi-
cutes (which include pneumococci) and are believed to
be involved in niche competition. Circular bacteriocins
in other Gram-positive bacterial species have been
shown to permeabilise the bacterial cell membrane and
cause cell death. They are ribosomally-synthesised and
post-translationally modified to form a circular struc-
ture: as compared to a linear structure, the circular form
is more stable, less susceptible to protease degradation
and therefore more active. Circular bacteriocins poten-
tially have a role in drug design, delivery and therapeu-
tics, although many questions related to their structure,
function and mechanisms of action remain to be deter-
mined [14, 31, 32].
The pneumocyclicin cassettes we discovered were simi-
lar in genetic structure and predicted proteins to circular
bacteriocin cassettes characterised in other Gram-positive
species. Nucleotide sequence similarity among the pneu-
mocyclicin cassettes was high and the majority of cassettes
were found in just seven pneumococcal CCs. It is curious
that this cassette is just upstream of comAB – genes that
have been shown to be essential to the development of
competence, which is a specific point in the growth cycle
during which a pneumococcus can take up and incorp-
orate exogenous DNA into its genome [39, 40]. Recom-
bination and transformation play a major role in the
evolution of the pneumococcus; therefore, it will be cru-
cial to understand not just the structure and function of
Table 6 Distribution of pneumocyclicin cassette alleles among pneumococcal clonal complexes (CCs)
Clonal complex: 1094 124 199 66 113 156/162 439 Other CCa Total (n)
No. of genomes: 22 19 12 10 10 10 9 23 115
Years of isolation: 1978-1988 1952-2005 1999-2005 1952-2007 1939-1999 1962-2008 1945-1996 1916-2007 1916-2008
Cluster A alleles 11 16 1 17
26 14 1 15
4 7 6 1 14
2 10 0 10
25 7 0 7
1 7 0 7
19 5 0 5
Otherb 1 2 5 0 3 5 3 12 31
Total A 22 18 12 10 10 10 9 15 106






Total B 1 8 9
aEach of the ‘Other’ CCs contributed ≤3 isolates to the Other CCs total
bEach of the ‘Other’ alleles was detected 1 or 2 times
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pneumocyclicin but the potential impact that expression
of pneumocyclicin genes may or may not have on com-
petence induction.
Among blp bacteriocin cassettes, there was a wide rep-
ertoire of putative bacteriocin and immunity genes in
the BIR region. Many individual cassettes possessed
multiple putative bacteriocin genes and immunity genes:
for example, Category 19 possessed six bacteriocin genes,
six immunity genes and two CAAX protease genes, and
genomes in six of the Category 19 Groups also possessed
a cluster A pneumocyclicin cassette. Further work will be
required to confirm the function of the genes in the BIR
region and understand the biology that underpins the di-
versity of bacteriocin and immunity proteins. Does the
possession of multiple bacteriocin and immunity genes
simply mean the pneumococcus has an increased reper-
toire of bacteriocin arsenal and broadened immunity? A
recent paper provided theoretical support for high bacteri-
ocin diversity within a bacterial population and demon-
strated that the maintenance of multiple bacteriocin and
immunity types relied upon two key factors: circulating
strains that were immune to the toxic effect of bacterio-
cins; and individual strains/lineages that were able to pro-
duce multiple bacteriocins and/or immunity proteins [41].
Is there a fitness cost associated with possession of mul-
tiple bacteriocin and immunity genes? Do some of these
genes have alternative functions? Interestingly, a recent
study demonstrated upregulation of blp bacteriocin genes
in a pneumococcal infection animal model, possibly sug-
gesting a role for some blp genes in pathogenesis and/or
virulence [42].
We also evaluated the blp cassette diversity in the
context of the pneumococcal population structure and
found that some blp bacteriocins were found in many
CCs whilst others seem to be restricted to one predom-
inant CC. There was no obvious association between blp
cassette type and serotype. Interestingly, some blp bac-
teriocin cassettes were genetically stable over many
decades; although not surprisingly, patterns of putative
large-fragment recombination similar to that previously
reported in other recent pneumococcal studies were also
identified [8, 10, 43].
Pneumococcal competition appears to be more com-
plicated than just producing a bacteriocin peptide to kill
competitors and an immunity protein to protect itself. Is
the observed diversity of pneumococcal bacteriocins
and/or the possession of multiple bacteriocin and im-
munity genes a reflection of a wider target specificity de-
signed for nasopharyngeal competition? The paediatric
nasopharynx is colonised by a variety of different micro-
organisms so it may be that the targets of the blp bacte-
riocins and pneumocyclicin are not solely pneumococci,
but also viridans streptococci, Haemophilus, Moraxella,
and others [13]. In previous work, Lux and colleagues
investigated the in vitro inhibitory activity of pneumococci
that produced bacteriocins using Micrococcus luteus and
Lactococcus lactis as indicator strains, and they tested three
blp bacteriocin-producing pneumococci against other oral
streptococci and observed some inhibition [21]. Therefore,
it is possible that the bacteriocins described here are pre-
dominantly mediating pneumococcal population-level in-
teractions, but that they are also central to the interactions
between pneumococci and other bacterial species residing
in the nasopharynx.
Moreover, there is evidence that bacteria can engage
in cooperative efforts within an ecological niche, often
by means of quorum sensing whereby an individual
detects and responds to an extracellular signal. However,
this can result in ‘social cheaters’ – individuals who
benefit from the cooperative efforts of the population
without the fitness cost of exhibiting the specific traits
themselves [15]. Son and colleagues demonstrated po-
tential cheating behaviour among pneumococcal strains
that produced immunity proteins but not the signalling
pheromone or bacteriocins (due to frameshifted se-
quences), thereby avoiding costly bacteriocin produc-
tion [22]. Intriguingly, we noticed that some alleles of
pcyB in the pneumocyclicin cassette were frameshifted
in a similar manner. Future studies will need to be de-
signed to determine the intra- and interspecies activity
of pneumococcal bacteriocins and the potential for a
cheater phenotype among pneumococci with pneumo-
cyclicin cassettes.
Conclusions
Vast quantities of bacterial genome data have been gen-
erated in recent years and we used bioinformatics and
computational biology tools to decipher the sequence-
based evidence for bacteriocins, after which experimental
studies can be designed to investigate specific hypotheses
using carefully-selected candidate strains. One can look
both forward and backward using these data: existing
experimental evidence guides the interpretation of the
genomic data, the design of new studies and the selection
of test strains, but existing experimental data can also be
reinterpreted based on genome sequence data. The se-
quence data are only predictive of function, but access to
such comprehensive data is an efficient and cost-effective
starting point to the challenging experimental work and




The study dataset consisted of whole genome sequence
data for 336 pneumococcal isolates recovered from
1916 to 2008 in 32 different countries (Additional file 1:
Table S1): 206 published genomes [10, 43–46] and 130
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GenBank genomes [47]. Ethical approval was not re-
quired to use any of the isolates in this study. Where
not previously published or available online, serotype/
group, multilocus sequence type and clonal complex
were assigned as previously described [43].
Classification of blp cassettes and prototype selection
Genomes were initially divided into groups based on ap-
proximate allelic profiles, as determined by a combin-
ation of two BIGSdb Genome Comparator [48] analyses,
using as references the genes blpS through to pncP from
the TIGR4 genome, and blpQ, pncT and pncW from the
2306 genome [21]. After sequence assembly, cassettes
were divided into ‘Categories’ on the basis of gene pres-
ence and synteny, and into ‘Groups’ on the basis of se-
quence similarity, ignoring the presence of IS elements.
When Categories were assigned, predictions of function-
ality were not taken into account.
Based on sequence alignments, separate Groups were
created for sequences that differed by >15 nucleotide
substitutions. Where the presence of an indel changed
gene organisation separate Categories were assigned. A
Group prototype was chosen based upon two criteria: i)
fully sequenced, assembled and gap-free cassette (although
gaps within IS elements were allowed); and ii) the cassette
sequence from the oldest pneumococcus.
Identification and assembly of blp cassette sequences
The blp cassette was defined as the genes between and
including blpT and pncP. Completeness of the assem-
blies was checked by comparing automated gene predic-
tions to expected gene presence based on the allelic
profile, and by interrogating each genome for all known
blp genes and those newly identified in this study. We
also performed a second round of assemblies, this time
using high throughput sequencing reads and their qual-
ity scores as coded in fastq files. Selected cassettes were
re-assembled by mapping of the Illumina reads to the
original Velvet contigs with SMALT, followed by inspec-
tion, correction, and manual joining of relevant contigs
in Gap5 [49, 50]. IS elements within blp cassettes were
not assembled but identified by their end sequences and
left as gaps in the sequence database. After extraction of
the cassette sequences into fasta files, the 5’ and 3’ ends
of each IS element were trimmed to 25 bp and joined by
Ns, so as to match the length listed for the specific IS
element by ISfinder [51].
Gene prediction and annotation
Genes were predicted with Prokka [52], Artemis was
used for sequence visualisation and manual editing of
annotations [53], and RATT was used to transfer anno-
tations between genomes with similar cassettes [54]. The
coding sequence (CDS) features predicted by Prokka
were modified in some cases: i) blpO and pncM, incon-
sistently predicted, were manually annotated; ii) blpP,
not predicted in any genomes, was manually annotated
where its sequence was present because of prior experi-
mental evidence for a role in immunity [20]; iii) bacteri-
ocin CDSs with multiple putative start codons close
together were adapted to start at M(D/N)T; iv) CDSs re-
lated to IS elements were replaced by mobile element
features; and v) frameshifted genes were labelled, except
within the transport region where CDSs were ambigu-
ously organised and thus left as originally predicted by
Prokka. Functional annotation was based on previously
published literature, BLAST searches of non-redundant
databases, and interrogation of the BAGEL3 [55] and
BACTIBASE databases [56].Sequence and annotation
files for blp cassette prototypes are found in Additional
file 9.
Identification and annotation of pneumocyclicin cassettes
The pneumocyclicin (pcy) cassette was defined as the
genes between and including pfgR and pcyE and identi-
fied as described above. The cassettes were separated
into nucleotide alleles using the NRDB tool [57] and
assigned to phylogenetic clusters with MEGA5 [58].
Gene prediction and annotation with Prokka was com-
plemented with manual BLAST searches and analysis
through BAGEL3 to confirm its nature as a bacteriocin
cassette.Sequence and annotation files for all pcy alleles
are found in Additional file 10.
Software used for sequence analyses and visualisation
BIGSdb [48] was used to store and query assembled blp
cassette prototype sequences and associated metadata.
BLAST searches were performed in BIGSdb or using BioE-
dit [59]. Sequence alignments and phylogenetic analyses
were performed with MEGA5 and progressiveMauve [60].
Bacteriocin cassettes were visualised with DNAPlotter [61]
and Inkscape [62].
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